Controlled trials with morantel tartrate plus diethylcarbamazine given to lambs infected experimentally with Haemonchus contortus, Ostertagia circumcincta, Nematodirus battus, Trichostrongylus colubriformis and Dictyocaulus filaria.
D000284:Administration, Oral; D000818:Animals; D000871:Anthelmintics / Q000627:therapeutic use*; D004022:Dictyocaulus Infections / Q000188:drug therapy*; D004049:Diethylcarbamazine / Q000627:therapeutic use*; D005260:Female; D008297:Male; D010270:Parasite Egg Count; D011743:Pyrimidines / Q000627:therapeutic use*; D012756:Sheep; D012757:Sheep Diseases / Q000188:drug therapy; D013644:Tartrates / Q000627:therapeutic use; D013876:Thiophenes / Q000627:therapeutic use; D014252:Trichostrongyloidiasis / Q000188:drug therapy / Q000662:veterinary*
D000871:Anthelmintics; D011743:Pyrimidines; D013644:Tartrates; D013876:Thiophenes; D004049:Diethylcarbamazine